Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Future Cardiology
(ISSN: 1479-6678,1744-8298)
This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.
Clinical, ECG and hemodynamic evaluation are established methods for diagnosis of pericardial disease, but advances in cardiac CT and MRI are quickly upping the diagnostic game. . .
Plain language summary of the EMPEROR-Preserved study looking at the effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes.
Drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction: plain language summary of the EMPEROR-Preserved study.